GenREY is a physician-scientist-led biotechnology platform built for the US and GCC founded in Texas by MDs, PhDs, Biomedical Scientists, Engineers, Clinicians and Business executives translating regenerative science into clinical, commercial, and sovereign healthcare program focusing on impactful bench to bedside clinical translation.
GenREY was built where medicine, biology, robotics, and translational science meet, where the work of physicians, engineers, and scientists converges into a single platform-grade infrastructure.
From a Texas base, the organization operates seven active R&D programs spanning regenerative medicine, organ bioengineering, genomic intelligence, and precision therapeutics, engineered to be portable, scalable, and open to institutional partnership.
The footprint behind the platform: a Texas-based engine translating research into clinical impact.
We translate the breakthroughs of regenerative biology: cellular repair, tissue engineering, genomic intelligence, into platform-grade technologies that restore, rebuild, and extend human health at population scale.
A single operating layer that translates physician-led regenerative-science innovation into therapies, registries, and capabilities, open to sovereign, academic, and institutional partners worldwide.
Data bank & science, rare disease registries, genetic characterization, building real-world evidence for new treatment modalities.
Stem cells, exosomes, and Wnt-signal restoration: the molecular substrate of regenerative medicine.
iREY next generation hair restoration platform - turning simple biologics into clinical signal.
Portable IP, composable architecture, and infrastructure designed to scale across jurisdictions.
Partner-led scaling, invitation-led collaboration, and the human work of putting science back into care.
GenREY is built where medicine, biology, robotics, and translational science meet, turning physician-led innovation into platform-grade biotechnology, then opening that platform to the institutional partners who will help it reach the people who need it.
Founders are practicing physicians and scientists. Clinical reality shapes every protocol, device, and pathway.
Engineered as an integrated infrastructure, not a portfolio of disconnected products.
Bench-to-bedside built into the operating model: discovery, IP, and deployment under one roof.
Stem cells, exosomes, and regenerative biology sit at the center of every program GenREY runs.
AI-driven omics and rare-disease intelligence. Precision built in from discovery forward.
Designed for sovereign, academic, and institutional collaboration across jurisdictions.
GenREY measures progress not by the number of products shipped, but by the infrastructure that outlasts them.
Active clinical-translation infrastructure running, deploying, and reporting in real settings.
Long-arc patient and outcomes data architected to compound in value across decades.
Clinical-translation talent advancing the field, independent of any single product or program.
If your work belongs in this future, convene with us.